Atomic AI

Atomic AI is a San Francisco-based biotechnology company operating at the intersection of artificial intelligence and structural biology. It applies proprietary machine learning models, including large language models trained on chemical mapping data, to purposefully design highly selective and potent small molecules against traditionally undruggable RNA targets. The company's interdisciplinary team of ML and RNA biology experts is guided by scientific advisors from Bristol-Myers Squibb, Stanford, and UC San Diego, with a mission to build the world's premier AI platform for RNA drug discovery.